UBS Maintains Neutral on Kimberly-Clark, Raises Price Target to $113
Kimberly-Clark Corporation Announces Extension of the Expiration Date for Exchange Offers for Kenvue Notes
Canaccord Genuity Initiates Coverage On Kimberly-Clark with Hold Rating, Announces Price Target of $105
Jim Cramer Calls Kimberly-Clark a Hated Dividend King. Is He Right?
Reported Earlier, Kimberly-Clark Prices $4.9B Senior Notes Offering In Five Tranches To Help Fund Kenvue Acquisition Cash Consideration
Kimberly-Clark Corporation Announces Pricing of $4.9 Billion Private Offering of Senior Notes
Kimberly-Clark vs. Clorox: Which Dividend Stock Pays You More in 10 Years?
Better Dividend Stock for Retirees: Kimberly-Clark vs. Hormel
Better Dividend Stock for Retirees: Kimberly-Clark vs. Unilever
Kimberly-Clark Launches Big Dreams™ Diapers and Wipes, exclusively in Amazon's stores
Kimberly-Clark's Reiterated Guidance Could Support Shares Despite Weak Sales, UBS Says
BNP Paribas Maintains Neutral on Kimberly-Clark, Raises Price Target to $110
'Kimberly-Clark Readies Bond Sale Ahead of Tylenol Maker Purchase' - Bloomberg
Kimberly Clark (KMB) Stock Trades At A Discount As Shares Fell 13%
Kimberly Clark (KMB) Dividend Growth Streak Is Under Pressure
Kimberly-Clark Shares Rise 1.8% as Preliminary Q3 Earnings Beat Expectations
Huggies Maker Kimberly-Clark Sticks To 2026 Profit Outlook
Kimberly-Clark shares rise following preliminary Q3 earnings beat
Kimberly-Clark Announces Preliminary Third Quarter 2026 Results and Provides Full Year 2026 Outlook Consistent with Previous Expectations
Cramer's Mad Dash: Kimberly-Clark Corporation
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.